// App-Quantinova.ai

1157M-92 : IS THE USE OF DRUG-ELUTING STENTS RELATED TO THE RISK OF TARGET VESSEL REVASCULARIZATION

Researchers

Presenter

  • David J. Malenka

Principal Investigators

  • Harold Dauerman

  • Alan Wiseman

  • Patrick Magnus

  • David Zlotnick

  • Richard Boss

  • David Goldberg

  • William Phillips

  • Thomas Ryan

  • Mirle Kellett

  • Matthew Watkins

  • John Robb

  • John Jayne

Medical Centers

  • The Northern New England Cardiovascular Disease Study Group, Dartmouth-Hitchcock Medical Center, Lebanon

Locations

  • Lebanon

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved